- Home
- / Kolon TissueGene
Kolon TissueGene
Kolon TissueGene Summary
Company Summary
- Overview
- Kolon TissueGene is a company developing cell therapies to target various orthopedic diseases and degenerative disorders. Its main product is INVOSSA, a cell and gene therapy for osteoarthritis.
- Type
- Private
- Status
- Active
- Founded
- 1999
- HQ
- Rockville, MD, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Sung Han, Chief Executive Officer, Director
LocationsView all
1 location detected
Rockville, MD HQ
United States
9713 Key W Ave #300